Edap Tms S.a. (EDAP) 10-Year Financial Performance & Capital Metrics

EDAP • • Industrial / General

HealthcareMedical DevicesSurgical & Minimally Invasive DevicesSurgical Energy & Ablation Systems

AboutEDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.Show more

Revenue $64M +6.1%
EBITDA -$18M -0.4%
Net Income -$19M +10.2%
EPS (Diluted) -0.51 +10.5%
Gross Margin 41.42% +2.5%
EBITDA Margin -28.03% +5.4%
Operating Margin -32.03% +2.3%
Net Margin -29.66% +15.4%
ROE -38.88% -18.0%
ROIC -65.74% +12.1%
Debt/Equity 0.34 +130.0%
Interest Coverage -87.01 -1.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 94 (top 6%)
✓Trading near 52-week high

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.12%

5Y7.38%

3Y13.31%

TTM0.61%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM11.26%

EPS CAGR

10Y-

5Y-

3Y-

TTM12.98%

ROCE

10Y Avg-7.35%

5Y Avg-14.61%

3Y Avg-23.46%

Latest-36.6%

Peer Comparison

Surgical Energy & Ablation Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
BDMDBaird Medical Investment Holdings Limited	45.91M	1.25	2.55	17.74%	33.62%	33%	0.53
IVFINVO Fertility, Inc.	12.29M	0.81	-0.03	116.25%	-417.01%	-495.09%	0.78
AEMDAethlon Medical, Inc.	2.64M	2.71	-0.03			-0.2%	0.13
HYPDHyperion DeFi, Inc.	27.38M	3.35	-0.06	14.14%	-73.86%	-36.05%
NAOVNanoVibronix, Inc.	1.59M	1.46	-0.11	12.05%	-133.04%	-8.41%	0.19
ALURAllurion Technologies Inc.	23.21M	1.89	-0.16	-39.94%	-251.56%
RBOTVicarious Surgical Inc.	18.48M	2.86	-0.27			-380.42%	0.30
TELATELA Bio, Inc.	44.09M	0.99	-0.74	18.56%	-50.61%	-25.05%	1.51

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	32.25M	35.61M	35.75M	39.18M	44.91M	41.66M	44.07M	55.11M	60.42M	64.11M
Revenue Growth %	0.2%	0.1%	0%	0.1%	0.15%	-0.07%	0.06%	0.25%	0.1%	0.06%
Cost of Goods Sold+	18.47M	19.2M	20.94M	22.27M	23.91M	23.28M	25.64M	30.92M	36.01M	37.56M
COGS % of Revenue	0.57%	0.54%	0.59%	0.57%	0.53%	0.56%	0.58%	0.56%	0.6%	0.59%
Gross Profit+	13.79M	16.41M	14.81M	16.92M	21M	18.38M	18.42M	24.19M	24.41M	26.56M
Gross Margin %	0.43%	0.46%	0.41%	0.43%	0.47%	0.44%	0.42%	0.44%	0.4%	0.41%
Gross Profit Growth %	0.23%	0.19%	-0.1%	0.14%	0.24%	-0.12%	0%	0.31%	0.01%	0.09%
Operating Expenses+	13.3M	16.02M	16.84M	18.23M	18.8M	18.11M	20.04M	28.45M	44.22M	47.09M
OpEx % of Revenue	0.41%	0.45%	0.47%	0.47%	0.42%	0.43%	0.45%	0.52%	0.73%	0.73%
Selling, General & Admin	10.61M	12.15M	12.95M	14.14M	15.07M	13.61M	16.63M	23.53M	37.26M	39.36M
SG&A % of Revenue	0.33%	0.34%	0.36%	0.36%	0.34%	0.33%	0.38%	0.43%	0.62%	0.61%
Research & Development	2.69M	3.87M	3.88M	4.09M	3.73M	4.5M	4.76M	4.92M	6.96M	7.73M
R&D % of Revenue	0.08%	0.11%	0.11%	0.1%	0.08%	0.11%	0.11%	0.09%	0.12%	0.12%
Other Operating Expenses	0	0	0	0	-1K	0	-1.35M	0	1K	0
Operating Income+	488K	392K	-2.03M	-1.31M	2.2M	269K	-1.61M	-4.26M	-19.81M	-20.53M
Operating Margin %	0.02%	0.01%	-0.06%	-0.03%	0.05%	0.01%	-0.04%	-0.08%	-0.33%	-0.32%
Operating Income Growth %	1.28%	-0.2%	-6.17%	0.35%	2.67%	-0.88%	-6.99%	-1.64%	-3.65%	-0.04%
EBITDA+	1.49M	1.47M	-549.45K	209.29K	4.08M	2.37M	308K	-2.65M	-17.9M	-17.97M
EBITDA Margin %	0.05%	0.04%	-0.02%	0.01%	0.09%	0.06%	0.01%	-0.05%	-0.3%	-0.28%
EBITDA Growth %	2.78%	-0.02%	-1.37%	1.38%	18.49%	-0.42%	-0.87%	-9.6%	-5.76%	-0%
D&A (Non-Cash Add-back)	1M	1.07M	1.48M	1.52M	1.88M	2.1M	1.92M	1.61M	1.91M	2.56M
EBIT	-843K	4.5M	-249K	131K	2.36M	268K	-1.61M	-1.93M	-20.3M	-18.49M
Net Interest Income+	-52.12K	138K	599K	797K	-145K	-98K	-42K	236K	1.08M	560K
Interest Income	18.85K	21K	18K	19K	20K	10K	10K	404K	1.31M	796K
Interest Expense	70.97K	57K	44K	111K	165K	108K	52K	168K	232K	236K
Other Income/Expense	-1.4M	4.05M	1.73M	1.33M	-10K	-1.46M	2.5M	2.16M	-720K	1.8M
Pretax Income+	-907K	4.44M	-294K	20K	2.19M	-1.19M	893K	-2.1M	-20.53M	-18.73M
Pretax Margin %	-0.03%	0.12%	-0.01%	0%	0.05%	-0.03%	0.02%	-0.04%	-0.34%	-0.29%
Income Tax+	759K	602K	388K	358K	679K	516K	193K	837K	644K	289K
Effective Tax Rate %	1.84%	0.86%	2.32%	-16.9%	0.69%	1.43%	0.78%	1.4%	1.03%	1.02%
Net Income+	-1.67M	3.84M	-681K	-338K	1.51M	-1.7M	700K	-2.93M	-21.18M	-19.02M
Net Margin %	-0.05%	0.11%	-0.02%	-0.01%	0.03%	-0.04%	0.02%	-0.05%	-0.35%	-0.3%
Net Income Growth %	-2.26%	3.3%	-1.18%	0.5%	5.47%	-2.13%	1.41%	-5.19%	-6.22%	0.1%
Net Income (Continuing)	-1.67M	3.84M	-681K	-338K	1.51M	-1.7M	700K	-2.93M	-21.18M	-19.02M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.07	0.13	-0.02	-0.01	0.05	-0.06	0.02	-0.09	-0.57	-0.51
EPS Growth %	-2.07%	2.95%	-1.18%	0.5%	5.35%	-2.15%	1.38%	-4.81%	-5.68%	0.11%
EPS (Basic)	-0.07	0.14	-0.02	-0.01	0.05	-0.06	0.02	-0.09	-0.57	-0.51
Diluted Shares Outstanding	25.02M	29.37M	28.96M	29M	29.62M	29.15M	32.42M	34.39M	37M	37.29M
Basic Shares Outstanding	23.81M	27.82M	28.96M	29M	29.02M	29.15M	32.13M	34.39M	37M	37.29M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	33.04M	40.51M	39.74M	40.38M	42.1M	45.39M	67.38M	90.52M	78.48M	69.88M
Cash & Short-Term Investments	14.58M	21.99M	20M	19.46M	20.89M	24.7M	47.18M	63.14M	43.47M	29.84M
Cash Only	13.58M	21.99M	20M	19.46M	20.89M	24.7M	47.18M	63.14M	43.47M	29.84M
Short-Term Investments	1M	0	0	0	0	0	0	0	0	0
Accounts Receivable	10.74M	9.34M	11.57M	12.24M	11.33M	10.64M	12.12M	14.94M	16.96M	20.29M
Days Sales Outstanding	121.59	95.74	118.11	114.05	92.06	93.22	100.39	98.96	102.46	115.51
Inventory	6.15M	8.03M	6.74M	7.21M	8.18M	7.99M	7.5M	11.78M	15.11M	18.5M
Days Inventory Outstanding	121.57	152.65	117.48	118.22	124.85	125.24	106.74	139.08	153.17	179.74
Other Current Assets	2.07M	883K	1.06M	1.43M	1.26M	1.7M	-1K	0	2.28M	-3K
Total Non-Current Assets+	5.54M	6.08M	7.33M	8.36M	10.97M	9.8M	9.84M	10.61M	13.07M	16.19M
Property, Plant & Equipment	2.12M	2.77M	3.68M	4.21M	6.72M	5.6M	5.17M	5.99M	8.19M	10.34M
Fixed Asset Turnover	15.19x	12.86x	9.71x	9.31x	6.69x	7.44x	8.52x	9.21x	7.37x	6.20x
Goodwill	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M
Intangible Assets	39K	149K	527K	847K	770K	761K	728K	724K	1.08M	1.09M
Long-Term Investments	593K	299K	77K	26K	2K	0	0	0	0	0
Other Non-Current Assets	969K	436K	462K	546K	640K	1.03M	634K	656K	1.38M	1.52M
Total Assets+	38.58M	46.59M	46.9M	48.74M	53.07M	55.19M	77.23M	101.12M	91.55M	86.06M
Asset Turnover	0.84x	0.76x	0.76x	0.80x	0.85x	0.75x	0.57x	0.54x	0.66x	0.74x
Asset Growth %	0.2%	0.21%	0.01%	0.04%	0.09%	0.04%	0.4%	0.31%	-0.09%	-0.06%
Total Current Liabilities+	16.27M	15.01M	16.13M	16.81M	17.49M	21.5M	17.95M	21.71M	27.6M	37.81M
Accounts Payable	6.1M	5.96M	6.31M	6.3M	6.03M	5.71M	5.51M	6.64M	11.24M	12.56M
Days Payables Outstanding	120.52	113.3	110	103.22	92.12	89.48	78.44	78.39	113.88	122.03
Short-Term Debt	3.02M	1.84M	3.1M	4.17M	3.98M	7.17M	2.74M	3.45M	4.02M	8.65M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	1000K	1000K	83.75K	1000K
Other Current Liabilities	3.72M	3.37M	3.65M	2.72M	552K	3.65M	2.02M	2.35M	5.07M	3.23M
Current Ratio	2.03x	2.70x	2.46x	2.40x	2.41x	2.11x	3.75x	4.17x	2.84x	1.85x
Quick Ratio	1.65x	2.16x	2.05x	1.97x	1.94x	1.74x	3.34x	3.63x	2.30x	1.36x
Cash Conversion Cycle	122.63	135.09	125.59	129.05	124.8	128.98	128.69	159.65	141.75	173.21
Total Non-Current Liabilities+	7.88M	7.13M	5.61M	6.96M	8.22M	7.44M	9.22M	7.79M	7.03M	7.36M
Long-Term Debt	592K	384K	834K	1.34M	957K	1.14M	4.93M	3.59M	2M	2.16M
Capital Lease Obligations	294K	313K	528K	852K	2.38M	1.65M	1.32M	1.22M	1.31M	1.94M
Deferred Tax Liabilities	6.49M	6.1M	2.29M	3.77M	3.52M	0	0	0	0	0
Other Non-Current Liabilities	505K	334K	1.95M	1M	47K	4.64M	2.53M	2.71M	3.07M	2.9M
Total Liabilities	24.15M	22.14M	21.74M	23.78M	25.71M	28.95M	27.17M	29.49M	34.63M	45.17M
Total Debt+	4.15M	2.76M	4.72M	6.75M	8.66M	11.11M	10.01M	9.38M	8.42M	13.92M
Net Debt	-9.43M	-19.23M	-15.29M	-12.72M	-12.22M	-13.58M	-37.18M	-53.75M	-35.05M	-15.92M
Debt / Equity	0.29x	0.11x	0.19x	0.27x	0.32x	0.42x	0.20x	0.13x	0.15x	0.34x
Debt / EBITDA	2.78x	1.88x	-	32.24x	2.12x	4.68x	32.48x	-	-	-
Net Debt / EBITDA	-6.33x	-13.11x	-	-60.76x	-3.00x	-5.72x	-120.71x	-	-	-
Interest Coverage	6.88x	6.88x	-46.07x	-11.85x	13.34x	2.49x	-31.00x	-25.34x	-85.40x	-87.01x
Total Equity+	14.43M	24.45M	25.16M	24.96M	27.36M	26.25M	50.05M	71.63M	56.92M	40.9M
Equity Growth %	-0.05%	0.69%	0.03%	-0.01%	0.1%	-0.04%	0.91%	0.43%	-0.21%	-0.28%
Book Value per Share	0.58	0.83	0.87	0.86	0.92	0.90	1.54	2.08	1.54	1.10
Total Shareholders' Equity	14.43M	24.45M	25.16M	24.96M	27.36M	26.25M	50.05M	71.63M	56.92M	40.9M
Common Stock	3.35M	3.78M	3.82M	3.82M	3.83M	3.83M	4.39M	4.78M	4.85M	4.89M
Retained Earnings	-42.77M	-38.93M	-39.61M	-39.95M	-38.44M	-40.14M	-39.44M	-42.37M	-63.55M	-82.57M
Treasury Stock	-1.14M	-1.14M	-1.14M	-1.14M	-928K	-928K	-928K	-897K	-800K	-800K
Accumulated OCI	-3.57M	-3.95M	-3.6M	-3.75M	-3.44M	-3.06M	-3.59M	-3.83M	-4.49M	-4.89M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.34M	1.12M	-3.06M	175K	3.8M	2.25M	4.45M	-3.02M	-14.68M	-13.58M
Operating CF Margin %	0.04%	0.03%	-0.09%	0%	0.08%	0.05%	0.1%	-0.05%	-0.24%	-0.21%
Operating CF Growth %	2.32%	-0.16%	-3.73%	1.06%	20.71%	-0.41%	0.97%	-1.68%	-3.85%	0.07%
Net Income	-1.67M	3.84M	-681K	-338K	1.51M	-1.94M	700K	-2.93M	-21.18M	-19.02M
Depreciation & Amortization	1M	1.02M	1.57M	1.61M	1.88M	2.52M	1.92M	1.6M	1.91M	2.56M
Stock-Based Compensation	66K	360K	382K	289K	260K	0	1.9M	2.1M	6.87M	3.28M
Deferred Taxes	23K	65K	-153K	-153K	-106K	51.3K	-563K	48K	42K	-97K
Other Non-Cash Items	1.97M	-3.89M	-2.49M	39K	247K	1.75M	-33K	469K	583K	1.65M
Working Capital Changes	-56K	-287K	-1.69M	-1.27M	8K	-124.26K	521K	-4.32M	-2.9M	-1.96M
Change in Receivables	-1.79M	1.8M	-1.64M	-1.01M	908K	1.3M	-103K	-1.94M	-4.91M	-139K
Change in Inventory	-381K	-1.99M	669K	-704K	-1.04M	-631.54K	166K	-4.48M	-4.21M	-4.04M
Change in Payables	518K	-153K	426K	-70K	-249K	-481.07K	0	1.12M	0	0
Cash from Investing+	-541K	-384K	-2.03M	-1.57M	-1.53M	-2.29M	-1.64M	-2.38M	-4.34M	-4.12M
Capital Expenditures	-650K	-1.33M	-2.07M	-1.87M	-396K	-722.74K	-393K	-2.18M	-1.18M	-1.31M
CapEx % of Revenue	0.02%	0.04%	0.06%	0.05%	0.01%	0.02%	0.01%	0.04%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	109K	-58K	40K	300K	-1.12M	-1.57M	-1.26M	-195K	-3.17M	-2.81M
Cash from Financing+	1.99M	7.69M	2.87M	1.18M	-664K	3.65M	20.27M	21.74M	-911K	4.63M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	128K	0	115K	1K	310K	0	443K	648K	261K	115K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	688K	-207K	-5.13M	-1.69M	2.35M	1.65M	2.8M	-5.21M	-18.97M	-17.68M
FCF Margin %	0.02%	-0.01%	-0.14%	-0.04%	0.05%	0.04%	0.06%	-0.09%	-0.31%	-0.28%
FCF Growth %	1.34%	-1.3%	-23.79%	0.67%	2.39%	-0.3%	0.7%	-2.86%	-2.64%	0.07%
FCF per Share	0.03	-0.01	-0.18	-0.06	0.08	0.06	0.09	-0.15	-0.51	-0.47
FCF Conversion (FCF/Net Income)	-0.80x	0.29x	4.49x	-0.52x	2.51x	-1.32x	6.35x	1.03x	0.69x	0.71x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-11.27%	19.76%	-2.75%	-1.35%	5.78%	-6.36%	1.83%	-4.82%	-32.95%	-38.88%
Return on Invested Capital (ROIC)	6.02%	5.75%	-20.14%	-8.92%	12.06%	1.45%	-9.47%	-20.76%	-74.76%	-65.74%
Gross Margin	42.74%	46.08%	41.43%	43.17%	46.76%	44.11%	41.81%	43.9%	40.4%	41.42%
Net Margin	-5.17%	10.79%	-1.91%	-0.86%	3.37%	-4.09%	1.59%	-5.32%	-35.05%	-29.66%
Debt / Equity	0.29x	0.11x	0.19x	0.27x	0.32x	0.42x	0.20x	0.13x	0.15x	0.34x
Interest Coverage	6.88x	6.88x	-46.07x	-11.85x	13.34x	2.49x	-31.00x	-25.34x	-85.40x	-87.01x
FCF Conversion	-0.80x	0.29x	4.49x	-0.52x	2.51x	-1.32x	6.35x	1.03x	0.69x	0.71x
Revenue Growth	20.41%	10.41%	0.38%	9.61%	14.62%	-7.23%	5.77%	25.06%	9.64%	6.11%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Goods	-	-	-	-	-	16.18M	38.46M	42.33M	44.04M
Goods Growth	-	-	-	-	-	-	137.70%	10.06%	4.03%
Spare parts and services	-	-	-	-	-	6.35M	7M	11.91M	12.47M
Spare parts and services Growth	-	-	-	-	-	-	10.17%	70.20%	4.65%
RPP's and leases	-	-	-	-	-	3.11M	3.39M	6.18M	7.61M
RPP's and leases Growth	-	-	-	-	-	-	8.98%	82.34%	23.22%
Extension of Warranty	-	-	-	-	-	298K	-	-	-
Extension of Warranty Growth	-	-	-	-	-	-	-	-	-
Licenses and others.	-	-	-	-	-	6K	-	-	-
Licenses and others. Growth	-	-	-	-	-	-	-	-	-
Service	-	-	-	-	12K	6K	-	-	-
Service Growth	-	-	-	-	-	-50.00%	-	-	-
Manufactured Product Other	-	-	-	-	14.95M	-	-	-	-
Manufactured Product Other Growth	-	-	-	-	-	-	-	-	-
Parts And Services	-	-	-	-	5.73M	-	-	-	-
Parts And Services Growth	-	-	-	-	-	-	-	-	-
H I F U Treatments And Devices Leased	-	-	-	-	2.6M	-	-	-	-
H I F U Treatments And Devices Leased Growth	-	-	-	-	-	-	-	-	-
Extension Of Warranty	-	-	-	-	261K	-	-	-	-
Extension Of Warranty Growth	-	-	-	-	-	-	-	-	-
License And Service	-	-	-	-	12K	-	-	-	-
License And Service Growth	-	-	-	-	-	-	-	-	-
Product and Service, Other	-	60K	19K	52K	-	-	-	-	-
Product and Service, Other Growth	-	-	-68.33%	173.68%	-	-	-	-	-
Licenses and Others	-	60K	19K	52K	-	-	-	-	-
Licenses and Others Growth	-	-	-68.33%	173.68%	-	-	-	-	-
Urology Devices and Services (UDS)	13.49M	-	-	-	-	-	-	-	-
Urology Devices and Services (UDS) Growth	-	-	-	-	-	-	-	-	-
High Intensity Focused Ultrasound (HIFU)	5.71M	-	-	-	-	-	-	-	-
High Intensity Focused Ultrasound (HIFU) Growth	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Asia	-	-	14.12M	17.94M	15.87M	16.01M	17.94M	17.84M	19.04M
Asia Growth	-	-	-	27.06%	-11.52%	0.86%	12.04%	-0.53%	6.73%
USA	-	-	-	-	-	-	15.04M	16.72M	18.22M
USA Growth	-	-	-	-	-	-	-	11.18%	8.99%
Other geographical Areas	-	-	11.42M	10.38M	-	10.28M	11.5M	13.87M	15.61M
Other geographical Areas Growth	-	-	-	-9.13%	-	-	11.91%	20.57%	12.61%
France	-	-	-	-	-	12.25M	10.64M	12M	11.24M
France Growth	-	-	-	-	-	-	-13.17%	12.80%	-6.33%
United States	-	-	-	-	-	5.52M	-	-	-
United States Growth	-	-	-	-	-	-	-	-	-
Other Geographical Areas	-	-	-	-	10.15M	-	-	-	-
Other Geographical Areas Growth	-	-	-	-	-	-	-	-	-
U	-	-	-	-	5.61M	-	-	-	-
U Growth	-	-	-	-	-	-	-	-	-
FRANCE	-	-	11.58M	11.35M	-	-	-	-	-
FRANCE Growth	-	-	-	-1.96%	-	-	-	-	-
UNITED STATES	-	-	2.05M	5.19M	-	-	-	-	-
UNITED STATES Growth	-	-	-	153.61%	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Edap Tms S.a. (EDAP) reported $63.8M in revenue for fiscal year 2024. This represents a 186% increase from $22.3M in 2011.

Edap Tms S.a. (EDAP) grew revenue by 6.1% over the past year. This is steady growth.

Edap Tms S.a. (EDAP) reported a net loss of $19.6M for fiscal year 2024.

Dividend & Returns

Edap Tms S.a. (EDAP) has a return on equity (ROE) of -38.9%. Negative ROE indicates the company is unprofitable.

Edap Tms S.a. (EDAP) had negative free cash flow of $12.9M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Edap Tms S.a. (EDAP) 10-Year Financial Performance & Capital Metrics

EDAP • • Industrial / General

HealthcareMedical DevicesSurgical & Minimally Invasive DevicesSurgical Energy & Ablation Systems

Revenue $64M +6.1%
EBITDA -$18M -0.4%
Net Income -$19M +10.2%
EPS (Diluted) -0.51 +10.5%
Gross Margin 41.42% +2.5%
EBITDA Margin -28.03% +5.4%
Operating Margin -32.03% +2.3%
Net Margin -29.66% +15.4%
ROE -38.88% -18.0%
ROIC -65.74% +12.1%
Debt/Equity 0.34 +130.0%
Interest Coverage -87.01 -1.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 94 (top 6%)
✓Trading near 52-week high

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.12%

5Y7.38%

3Y13.31%

TTM0.61%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM11.26%

EPS CAGR

10Y-

5Y-

3Y-

TTM12.98%

ROCE

10Y Avg-7.35%

5Y Avg-14.61%

3Y Avg-23.46%

Latest-36.6%

Peer Comparison

Surgical Energy & Ablation Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
BDMDBaird Medical Investment Holdings Limited	45.91M	1.25	2.55	17.74%	33.62%	33%	0.53
IVFINVO Fertility, Inc.	12.29M	0.81	-0.03	116.25%	-417.01%	-495.09%	0.78
AEMDAethlon Medical, Inc.	2.64M	2.71	-0.03			-0.2%	0.13
HYPDHyperion DeFi, Inc.	27.38M	3.35	-0.06	14.14%	-73.86%	-36.05%
NAOVNanoVibronix, Inc.	1.59M	1.46	-0.11	12.05%	-133.04%	-8.41%	0.19
ALURAllurion Technologies Inc.	23.21M	1.89	-0.16	-39.94%	-251.56%
RBOTVicarious Surgical Inc.	18.48M	2.86	-0.27			-380.42%	0.30
TELATELA Bio, Inc.	44.09M	0.99	-0.74	18.56%	-50.61%	-25.05%	1.51

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	32.25M	35.61M	35.75M	39.18M	44.91M	41.66M	44.07M	55.11M	60.42M	64.11M
Revenue Growth %	0.2%	0.1%	0%	0.1%	0.15%	-0.07%	0.06%	0.25%	0.1%	0.06%
Cost of Goods Sold+	18.47M	19.2M	20.94M	22.27M	23.91M	23.28M	25.64M	30.92M	36.01M	37.56M
COGS % of Revenue	0.57%	0.54%	0.59%	0.57%	0.53%	0.56%	0.58%	0.56%	0.6%	0.59%
Gross Profit+	13.79M	16.41M	14.81M	16.92M	21M	18.38M	18.42M	24.19M	24.41M	26.56M
Gross Margin %	0.43%	0.46%	0.41%	0.43%	0.47%	0.44%	0.42%	0.44%	0.4%	0.41%
Gross Profit Growth %	0.23%	0.19%	-0.1%	0.14%	0.24%	-0.12%	0%	0.31%	0.01%	0.09%
Operating Expenses+	13.3M	16.02M	16.84M	18.23M	18.8M	18.11M	20.04M	28.45M	44.22M	47.09M
OpEx % of Revenue	0.41%	0.45%	0.47%	0.47%	0.42%	0.43%	0.45%	0.52%	0.73%	0.73%
Selling, General & Admin	10.61M	12.15M	12.95M	14.14M	15.07M	13.61M	16.63M	23.53M	37.26M	39.36M
SG&A % of Revenue	0.33%	0.34%	0.36%	0.36%	0.34%	0.33%	0.38%	0.43%	0.62%	0.61%
Research & Development	2.69M	3.87M	3.88M	4.09M	3.73M	4.5M	4.76M	4.92M	6.96M	7.73M
R&D % of Revenue	0.08%	0.11%	0.11%	0.1%	0.08%	0.11%	0.11%	0.09%	0.12%	0.12%
Other Operating Expenses	0	0	0	0	-1K	0	-1.35M	0	1K	0
Operating Income+	488K	392K	-2.03M	-1.31M	2.2M	269K	-1.61M	-4.26M	-19.81M	-20.53M
Operating Margin %	0.02%	0.01%	-0.06%	-0.03%	0.05%	0.01%	-0.04%	-0.08%	-0.33%	-0.32%
Operating Income Growth %	1.28%	-0.2%	-6.17%	0.35%	2.67%	-0.88%	-6.99%	-1.64%	-3.65%	-0.04%
EBITDA+	1.49M	1.47M	-549.45K	209.29K	4.08M	2.37M	308K	-2.65M	-17.9M	-17.97M
EBITDA Margin %	0.05%	0.04%	-0.02%	0.01%	0.09%	0.06%	0.01%	-0.05%	-0.3%	-0.28%
EBITDA Growth %	2.78%	-0.02%	-1.37%	1.38%	18.49%	-0.42%	-0.87%	-9.6%	-5.76%	-0%
D&A (Non-Cash Add-back)	1M	1.07M	1.48M	1.52M	1.88M	2.1M	1.92M	1.61M	1.91M	2.56M
EBIT	-843K	4.5M	-249K	131K	2.36M	268K	-1.61M	-1.93M	-20.3M	-18.49M
Net Interest Income+	-52.12K	138K	599K	797K	-145K	-98K	-42K	236K	1.08M	560K
Interest Income	18.85K	21K	18K	19K	20K	10K	10K	404K	1.31M	796K
Interest Expense	70.97K	57K	44K	111K	165K	108K	52K	168K	232K	236K
Other Income/Expense	-1.4M	4.05M	1.73M	1.33M	-10K	-1.46M	2.5M	2.16M	-720K	1.8M
Pretax Income+	-907K	4.44M	-294K	20K	2.19M	-1.19M	893K	-2.1M	-20.53M	-18.73M
Pretax Margin %	-0.03%	0.12%	-0.01%	0%	0.05%	-0.03%	0.02%	-0.04%	-0.34%	-0.29%
Income Tax+	759K	602K	388K	358K	679K	516K	193K	837K	644K	289K
Effective Tax Rate %	1.84%	0.86%	2.32%	-16.9%	0.69%	1.43%	0.78%	1.4%	1.03%	1.02%
Net Income+	-1.67M	3.84M	-681K	-338K	1.51M	-1.7M	700K	-2.93M	-21.18M	-19.02M
Net Margin %	-0.05%	0.11%	-0.02%	-0.01%	0.03%	-0.04%	0.02%	-0.05%	-0.35%	-0.3%
Net Income Growth %	-2.26%	3.3%	-1.18%	0.5%	5.47%	-2.13%	1.41%	-5.19%	-6.22%	0.1%
Net Income (Continuing)	-1.67M	3.84M	-681K	-338K	1.51M	-1.7M	700K	-2.93M	-21.18M	-19.02M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.07	0.13	-0.02	-0.01	0.05	-0.06	0.02	-0.09	-0.57	-0.51
EPS Growth %	-2.07%	2.95%	-1.18%	0.5%	5.35%	-2.15%	1.38%	-4.81%	-5.68%	0.11%
EPS (Basic)	-0.07	0.14	-0.02	-0.01	0.05	-0.06	0.02	-0.09	-0.57	-0.51
Diluted Shares Outstanding	25.02M	29.37M	28.96M	29M	29.62M	29.15M	32.42M	34.39M	37M	37.29M
Basic Shares Outstanding	23.81M	27.82M	28.96M	29M	29.02M	29.15M	32.13M	34.39M	37M	37.29M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	33.04M	40.51M	39.74M	40.38M	42.1M	45.39M	67.38M	90.52M	78.48M	69.88M
Cash & Short-Term Investments	14.58M	21.99M	20M	19.46M	20.89M	24.7M	47.18M	63.14M	43.47M	29.84M
Cash Only	13.58M	21.99M	20M	19.46M	20.89M	24.7M	47.18M	63.14M	43.47M	29.84M
Short-Term Investments	1M	0	0	0	0	0	0	0	0	0
Accounts Receivable	10.74M	9.34M	11.57M	12.24M	11.33M	10.64M	12.12M	14.94M	16.96M	20.29M
Days Sales Outstanding	121.59	95.74	118.11	114.05	92.06	93.22	100.39	98.96	102.46	115.51
Inventory	6.15M	8.03M	6.74M	7.21M	8.18M	7.99M	7.5M	11.78M	15.11M	18.5M
Days Inventory Outstanding	121.57	152.65	117.48	118.22	124.85	125.24	106.74	139.08	153.17	179.74
Other Current Assets	2.07M	883K	1.06M	1.43M	1.26M	1.7M	-1K	0	2.28M	-3K
Total Non-Current Assets+	5.54M	6.08M	7.33M	8.36M	10.97M	9.8M	9.84M	10.61M	13.07M	16.19M
Property, Plant & Equipment	2.12M	2.77M	3.68M	4.21M	6.72M	5.6M	5.17M	5.99M	8.19M	10.34M
Fixed Asset Turnover	15.19x	12.86x	9.71x	9.31x	6.69x	7.44x	8.52x	9.21x	7.37x	6.20x
Goodwill	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M
Intangible Assets	39K	149K	527K	847K	770K	761K	728K	724K	1.08M	1.09M
Long-Term Investments	593K	299K	77K	26K	2K	0	0	0	0	0
Other Non-Current Assets	969K	436K	462K	546K	640K	1.03M	634K	656K	1.38M	1.52M
Total Assets+	38.58M	46.59M	46.9M	48.74M	53.07M	55.19M	77.23M	101.12M	91.55M	86.06M
Asset Turnover	0.84x	0.76x	0.76x	0.80x	0.85x	0.75x	0.57x	0.54x	0.66x	0.74x
Asset Growth %	0.2%	0.21%	0.01%	0.04%	0.09%	0.04%	0.4%	0.31%	-0.09%	-0.06%
Total Current Liabilities+	16.27M	15.01M	16.13M	16.81M	17.49M	21.5M	17.95M	21.71M	27.6M	37.81M
Accounts Payable	6.1M	5.96M	6.31M	6.3M	6.03M	5.71M	5.51M	6.64M	11.24M	12.56M
Days Payables Outstanding	120.52	113.3	110	103.22	92.12	89.48	78.44	78.39	113.88	122.03
Short-Term Debt	3.02M	1.84M	3.1M	4.17M	3.98M	7.17M	2.74M	3.45M	4.02M	8.65M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	1000K	1000K	83.75K	1000K
Other Current Liabilities	3.72M	3.37M	3.65M	2.72M	552K	3.65M	2.02M	2.35M	5.07M	3.23M
Current Ratio	2.03x	2.70x	2.46x	2.40x	2.41x	2.11x	3.75x	4.17x	2.84x	1.85x
Quick Ratio	1.65x	2.16x	2.05x	1.97x	1.94x	1.74x	3.34x	3.63x	2.30x	1.36x
Cash Conversion Cycle	122.63	135.09	125.59	129.05	124.8	128.98	128.69	159.65	141.75	173.21
Total Non-Current Liabilities+	7.88M	7.13M	5.61M	6.96M	8.22M	7.44M	9.22M	7.79M	7.03M	7.36M
Long-Term Debt	592K	384K	834K	1.34M	957K	1.14M	4.93M	3.59M	2M	2.16M
Capital Lease Obligations	294K	313K	528K	852K	2.38M	1.65M	1.32M	1.22M	1.31M	1.94M
Deferred Tax Liabilities	6.49M	6.1M	2.29M	3.77M	3.52M	0	0	0	0	0
Other Non-Current Liabilities	505K	334K	1.95M	1M	47K	4.64M	2.53M	2.71M	3.07M	2.9M
Total Liabilities	24.15M	22.14M	21.74M	23.78M	25.71M	28.95M	27.17M	29.49M	34.63M	45.17M
Total Debt+	4.15M	2.76M	4.72M	6.75M	8.66M	11.11M	10.01M	9.38M	8.42M	13.92M
Net Debt	-9.43M	-19.23M	-15.29M	-12.72M	-12.22M	-13.58M	-37.18M	-53.75M	-35.05M	-15.92M
Debt / Equity	0.29x	0.11x	0.19x	0.27x	0.32x	0.42x	0.20x	0.13x	0.15x	0.34x
Debt / EBITDA	2.78x	1.88x	-	32.24x	2.12x	4.68x	32.48x	-	-	-
Net Debt / EBITDA	-6.33x	-13.11x	-	-60.76x	-3.00x	-5.72x	-120.71x	-	-	-
Interest Coverage	6.88x	6.88x	-46.07x	-11.85x	13.34x	2.49x	-31.00x	-25.34x	-85.40x	-87.01x
Total Equity+	14.43M	24.45M	25.16M	24.96M	27.36M	26.25M	50.05M	71.63M	56.92M	40.9M
Equity Growth %	-0.05%	0.69%	0.03%	-0.01%	0.1%	-0.04%	0.91%	0.43%	-0.21%	-0.28%
Book Value per Share	0.58	0.83	0.87	0.86	0.92	0.90	1.54	2.08	1.54	1.10
Total Shareholders' Equity	14.43M	24.45M	25.16M	24.96M	27.36M	26.25M	50.05M	71.63M	56.92M	40.9M
Common Stock	3.35M	3.78M	3.82M	3.82M	3.83M	3.83M	4.39M	4.78M	4.85M	4.89M
Retained Earnings	-42.77M	-38.93M	-39.61M	-39.95M	-38.44M	-40.14M	-39.44M	-42.37M	-63.55M	-82.57M
Treasury Stock	-1.14M	-1.14M	-1.14M	-1.14M	-928K	-928K	-928K	-897K	-800K	-800K
Accumulated OCI	-3.57M	-3.95M	-3.6M	-3.75M	-3.44M	-3.06M	-3.59M	-3.83M	-4.49M	-4.89M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.34M	1.12M	-3.06M	175K	3.8M	2.25M	4.45M	-3.02M	-14.68M	-13.58M
Operating CF Margin %	0.04%	0.03%	-0.09%	0%	0.08%	0.05%	0.1%	-0.05%	-0.24%	-0.21%
Operating CF Growth %	2.32%	-0.16%	-3.73%	1.06%	20.71%	-0.41%	0.97%	-1.68%	-3.85%	0.07%
Net Income	-1.67M	3.84M	-681K	-338K	1.51M	-1.94M	700K	-2.93M	-21.18M	-19.02M
Depreciation & Amortization	1M	1.02M	1.57M	1.61M	1.88M	2.52M	1.92M	1.6M	1.91M	2.56M
Stock-Based Compensation	66K	360K	382K	289K	260K	0	1.9M	2.1M	6.87M	3.28M
Deferred Taxes	23K	65K	-153K	-153K	-106K	51.3K	-563K	48K	42K	-97K
Other Non-Cash Items	1.97M	-3.89M	-2.49M	39K	247K	1.75M	-33K	469K	583K	1.65M
Working Capital Changes	-56K	-287K	-1.69M	-1.27M	8K	-124.26K	521K	-4.32M	-2.9M	-1.96M
Change in Receivables	-1.79M	1.8M	-1.64M	-1.01M	908K	1.3M	-103K	-1.94M	-4.91M	-139K
Change in Inventory	-381K	-1.99M	669K	-704K	-1.04M	-631.54K	166K	-4.48M	-4.21M	-4.04M
Change in Payables	518K	-153K	426K	-70K	-249K	-481.07K	0	1.12M	0	0
Cash from Investing+	-541K	-384K	-2.03M	-1.57M	-1.53M	-2.29M	-1.64M	-2.38M	-4.34M	-4.12M
Capital Expenditures	-650K	-1.33M	-2.07M	-1.87M	-396K	-722.74K	-393K	-2.18M	-1.18M	-1.31M
CapEx % of Revenue	0.02%	0.04%	0.06%	0.05%	0.01%	0.02%	0.01%	0.04%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	109K	-58K	40K	300K	-1.12M	-1.57M	-1.26M	-195K	-3.17M	-2.81M
Cash from Financing+	1.99M	7.69M	2.87M	1.18M	-664K	3.65M	20.27M	21.74M	-911K	4.63M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	128K	0	115K	1K	310K	0	443K	648K	261K	115K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	688K	-207K	-5.13M	-1.69M	2.35M	1.65M	2.8M	-5.21M	-18.97M	-17.68M
FCF Margin %	0.02%	-0.01%	-0.14%	-0.04%	0.05%	0.04%	0.06%	-0.09%	-0.31%	-0.28%
FCF Growth %	1.34%	-1.3%	-23.79%	0.67%	2.39%	-0.3%	0.7%	-2.86%	-2.64%	0.07%
FCF per Share	0.03	-0.01	-0.18	-0.06	0.08	0.06	0.09	-0.15	-0.51	-0.47
FCF Conversion (FCF/Net Income)	-0.80x	0.29x	4.49x	-0.52x	2.51x	-1.32x	6.35x	1.03x	0.69x	0.71x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-11.27%	19.76%	-2.75%	-1.35%	5.78%	-6.36%	1.83%	-4.82%	-32.95%	-38.88%
Return on Invested Capital (ROIC)	6.02%	5.75%	-20.14%	-8.92%	12.06%	1.45%	-9.47%	-20.76%	-74.76%	-65.74%
Gross Margin	42.74%	46.08%	41.43%	43.17%	46.76%	44.11%	41.81%	43.9%	40.4%	41.42%
Net Margin	-5.17%	10.79%	-1.91%	-0.86%	3.37%	-4.09%	1.59%	-5.32%	-35.05%	-29.66%
Debt / Equity	0.29x	0.11x	0.19x	0.27x	0.32x	0.42x	0.20x	0.13x	0.15x	0.34x
Interest Coverage	6.88x	6.88x	-46.07x	-11.85x	13.34x	2.49x	-31.00x	-25.34x	-85.40x	-87.01x
FCF Conversion	-0.80x	0.29x	4.49x	-0.52x	2.51x	-1.32x	6.35x	1.03x	0.69x	0.71x
Revenue Growth	20.41%	10.41%	0.38%	9.61%	14.62%	-7.23%	5.77%	25.06%	9.64%	6.11%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Goods	-	-	-	-	-	16.18M	38.46M	42.33M	44.04M
Goods Growth	-	-	-	-	-	-	137.70%	10.06%	4.03%
Spare parts and services	-	-	-	-	-	6.35M	7M	11.91M	12.47M
Spare parts and services Growth	-	-	-	-	-	-	10.17%	70.20%	4.65%
RPP's and leases	-	-	-	-	-	3.11M	3.39M	6.18M	7.61M
RPP's and leases Growth	-	-	-	-	-	-	8.98%	82.34%	23.22%
Extension of Warranty	-	-	-	-	-	298K	-	-	-
Extension of Warranty Growth	-	-	-	-	-	-	-	-	-
Licenses and others.	-	-	-	-	-	6K	-	-	-
Licenses and others. Growth	-	-	-	-	-	-	-	-	-
Service	-	-	-	-	12K	6K	-	-	-
Service Growth	-	-	-	-	-	-50.00%	-	-	-
Manufactured Product Other	-	-	-	-	14.95M	-	-	-	-
Manufactured Product Other Growth	-	-	-	-	-	-	-	-	-
Parts And Services	-	-	-	-	5.73M	-	-	-	-
Parts And Services Growth	-	-	-	-	-	-	-	-	-
H I F U Treatments And Devices Leased	-	-	-	-	2.6M	-	-	-	-
H I F U Treatments And Devices Leased Growth	-	-	-	-	-	-	-	-	-
Extension Of Warranty	-	-	-	-	261K	-	-	-	-
Extension Of Warranty Growth	-	-	-	-	-	-	-	-	-
License And Service	-	-	-	-	12K	-	-	-	-
License And Service Growth	-	-	-	-	-	-	-	-	-
Product and Service, Other	-	60K	19K	52K	-	-	-	-	-
Product and Service, Other Growth	-	-	-68.33%	173.68%	-	-	-	-	-
Licenses and Others	-	60K	19K	52K	-	-	-	-	-
Licenses and Others Growth	-	-	-68.33%	173.68%	-	-	-	-	-
Urology Devices and Services (UDS)	13.49M	-	-	-	-	-	-	-	-
Urology Devices and Services (UDS) Growth	-	-	-	-	-	-	-	-	-
High Intensity Focused Ultrasound (HIFU)	5.71M	-	-	-	-	-	-	-	-
High Intensity Focused Ultrasound (HIFU) Growth	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Asia	-	-	14.12M	17.94M	15.87M	16.01M	17.94M	17.84M	19.04M
Asia Growth	-	-	-	27.06%	-11.52%	0.86%	12.04%	-0.53%	6.73%
USA	-	-	-	-	-	-	15.04M	16.72M	18.22M
USA Growth	-	-	-	-	-	-	-	11.18%	8.99%
Other geographical Areas	-	-	11.42M	10.38M	-	10.28M	11.5M	13.87M	15.61M
Other geographical Areas Growth	-	-	-	-9.13%	-	-	11.91%	20.57%	12.61%
France	-	-	-	-	-	12.25M	10.64M	12M	11.24M
France Growth	-	-	-	-	-	-	-13.17%	12.80%	-6.33%
United States	-	-	-	-	-	5.52M	-	-	-
United States Growth	-	-	-	-	-	-	-	-	-
Other Geographical Areas	-	-	-	-	10.15M	-	-	-	-
Other Geographical Areas Growth	-	-	-	-	-	-	-	-	-
U	-	-	-	-	5.61M	-	-	-	-
U Growth	-	-	-	-	-	-	-	-	-
FRANCE	-	-	11.58M	11.35M	-	-	-	-	-
FRANCE Growth	-	-	-	-1.96%	-	-	-	-	-
UNITED STATES	-	-	2.05M	5.19M	-	-	-	-	-
UNITED STATES Growth	-	-	-	153.61%	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Edap Tms S.a. (EDAP) reported $63.8M in revenue for fiscal year 2024. This represents a 186% increase from $22.3M in 2011.

Edap Tms S.a. (EDAP) grew revenue by 6.1% over the past year. This is steady growth.

Edap Tms S.a. (EDAP) reported a net loss of $19.6M for fiscal year 2024.

Dividend & Returns

Edap Tms S.a. (EDAP) has a return on equity (ROE) of -38.9%. Negative ROE indicates the company is unprofitable.

Edap Tms S.a. (EDAP) had negative free cash flow of $12.9M in fiscal year 2024, likely due to heavy capital investments.